Abbott Laboratories (ABT) is a health care equipment company in the Health Care sector. Listed on the NASDAQ, Abbott Laboratories is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $89.17.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $89.17 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 0.13% |
| Risk / Std Dev (Annualized) | 22.06% |
| Sharpe Ratio (rf=4.5%) | -0.20 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Health Care Equipment
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 0.13% with an annualized volatility of 22.06%. The Sharpe ratio of -0.20 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 155.32B |
| Enterprise Value | 182.8B |
| Trailing P/E | 24.98 |
| Forward P/E | 14.71 |
| Price to Book | 2.98 |
| Price to Sales | 3.44 |
| EV/Revenue | 4.05 |
| EV/EBITDA | 15.56 |
| Profitability | | | Profit Margin | 13.9% | | Operating Margin | 13.47% | | ROE | 12.33% | | ROA | 5.59% |
| Growth | | | Revenue Growth | 7.8% | | Earnings Growth | -19.7% |
| Dividend | | | Dividend Yield | 283.0% | | Payout Ratio | 67.23% | | 5Y Avg Yield | 182.0% |
| Financial Health | | | Total Revenue | 45.13B | | Total Debt | 34.14B | | Total Cash | 7.3B | | Free Cash Flow | 6.34B | | Operating Cash Flow | 9.46B |
| Price & Technical | | | 52W High | $139.06$ | | 52W Low | $81.97$ | | 50-Day Avg | $92.01$ | | 200-Day Avg | $115.14$ | | Beta | 0.62 | | Shares Outstanding | 1.74B | | Float Shares | 1.73B | | Insider Holdings | 0.5% | | Institutional Holdings | 82.67% | | Short Ratio | 1.73 | | Short % of Float | 1.41% |
| Analyst Targets | | | Target High | $135.0$ | | Target Low | $92.0$ | | Target Mean | $117.29$ | | Target Median | $115.0$ | | # of Analysts | 24 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.